论文部分内容阅读
目的:比较头孢地秦钠与头孢曲松钠对男性急性淋病患者抗淋球菌的疗效。方法:选取2014年8月—2015年9月间收治的男性急性淋菌性尿道炎患者110例,将其分为对照组55例和观察组55例;对照组患者给予头孢曲松钠治疗,观察组患者给予头孢地秦钠治疗,比较两组患者治疗后的总有效率、不良反应的发生率以及按疼痛VAS量表评分值和尿失禁症状评分值。结果:观察组患者治疗后的总有效率为96.36%优于对照组为85.45%,尿失禁症状评分值和VAS量表评分值均低于对照组(P<0.05);两组患者用药期间不良反应的发生率经组间比较其差异无统计学意义(P>0.05)。结论:采用头孢地秦钠治疗男性急性淋病的疗效优于头孢曲松钠的疗效。
Objective: To compare the curative effect of cefodizime sodium and ceftriaxone sodium against gonococci in male patients with acute gonorrhea. Methods: A total of 110 male patients with acute gonococcal urethritis admitted from August 2014 to September 2015 were selected and divided into control group (55 cases) and observation group (55 cases). Patients in the control group were treated with ceftriaxone sodium Group patients were given cefodizime sodium treatment, the total effective rate after treatment, the incidence of adverse reactions and pain VAS scores and urinary incontinence symptoms scores were compared between the two groups. Results: The total effective rate after treatment in the observation group was 96.36%, which was 85.45% higher than that in the control group. The urinary incontinence symptom scores and the VAS scale scores were lower than those in the control group (P <0.05) The incidence of the reaction between groups by the difference was not statistically significant (P> 0.05). Conclusion: The efficacy of cefodizime sodium in the treatment of acute gonorrhea in men is better than that of ceftriaxone sodium.